Skip to content

Dortmund, 8th September 2025

Susmita Ghosh, a doctoral student in the Biofluorescence Research Group, is one of three lead authors of a study published in the Journal of Neuroinflammation. Together with Ali Ata Tuz (ISAS and Universitätsklinikum Essen and Laura Karsch (Universitätsklinikum Essen), she investigated the connection between gut microbiota and neutrophil granulocytes. In this interview, the biologist discusses her research on proteins and the effect that neutrophils have on the brain following a stroke.

Susmita Ghosh sitzt am ultrasensitiven Massenspektrometer und stellt eine Proben ein.

Susmita Ghosh analyses samples of neutrophil granulocytes using an ultrasensitive mass spectrometer. Her aim is to understand how immune cells behave after a stroke.

© ISAS / Hannes Woidich

1. How did you come up with the link between gut microbiota, neutrophile activation and strokes?

Ghosh: In our previous papers, we observed that activated neutrophils have a negative impact on stroke outcomes. We wanted to find out why and identify the decisive factors. Meanwhile, Dr Vikramjeet Singh from University Hospital Essen was researching the link between gut microbiota and stroke outcomes. Together, we wanted to establish whether gut microbiota could trigger neutrophil activation upon stroke. To do this, Ali Tuz, Laura Karsch and I divided the parts of the study equally. While Ali and Laura brought in their expertise with imaging and flow cytometry techniques, I was responsible for the proteomic analyses using liquid chromatography-mass spectrometry (LC-MS). Since the neutrophils’ behaviour depends on their protein expression, we chose proteomic analysis to understand the neutrophiles’ behaviour after a stroke. From the brain of mice with stroke, we got only a handful of neutrophils, which is difficult for proteome analyses. Since I had already optimised the proteomics approach for low input samples in a previous study, it was easy to apply this method to investigate the gut microbiota’s influence on neutrophils.

2. What exactly did your results reveal about gut microbiota and neutrophile activation?

Ghosh: I analysed the proteome of neutrophils isolated from the brains and blood of mice that had experienced a stroke. Using label-free quantitative proteomics, I identified the changes in protein expression between neutrophils upon microbiota depletion compared to the control sample in which microbiota was present. This enabled us to infer that neutrophils from mice with depleted microbiota were less activated and provided greater support for tissue repair in the brain following a stroke. This finding indicates that gut microbes positively influence neutrophil activation after stroke, causing more and worsening existing inflammation. We were able to validate my results with those from other experiments, using ELISA (Enzyme-linked Immunosorbent Assay). This was important to us, as validating proteomic data is difficult and often missing in research papers.

Article Recommendation

Tuz, A. A., Ghosh, S., Karsch, L., Antler, M., Lakovic, V., Lohmann, S., Lehmann, A. H., Beer, A., Nagel, D., Jung, M., Hörenbaum, N., Kaygusuz, V., Qefalia, A., Alshaar, B., Amookazemi, N., Bolsega, S., Basic, M., Siveke, J. T., Heiles, S., Grüneboom, A., Lueong, S., Herz, J., Sickmann, A., Hagemann, N., Hasenberg, A., Hermann, D. M., Gunzer, M., Singh, V.

(2025) Gut microbiota deficiency reduces neutrophil activation and is protective after ischemic stroke. Journal of Neuroinflammation, 22, Nr. 137.

https://doi.org/10.1186/s12974-025-03448-w

3. How do your findings about the gut microbiota contribute to our understanding of its role after stroke, and what are the next steps in this line of research?

Ghosh: The gut microbiota is essential for our day-to-day life. However, our results suggest that healthy microbiota can have a negative influence on stroke outcomes due to activated neutrophils. But we still do not know how this microbiota-neutrophil-interaction occurs. If we manage to identify any factor that activates the neutrophils, we could try to inhibit it to reduce tissue damage. However, we also do not yet know if our findings apply to human gut microbiota. This is an exciting area of research with many questions still to be answered.

(The interview was conducted by Anna Becker.)

Share

Further articles

8th September 2025

Gut Flora & Stroke: How Microorganisms Influence Our Immune System

Which factors can activate immune cells after a stroke? This question was investigated by researchers at University Hospital Essen and ISAS. Their work focused on the gut microbiota.

23rd July 2025

3 Questions for Dr Ali Ata Tuz

In his doctorate, Dr Ali Ata Tuz researched the causes of immunodeficiency after strokes and was already working closely with ISAS at the time. Following this, he subsequently devoted himself to the behaviour of immune cells in the bioimaging research group at ISAS. In this interview, the physician talks about his path from the clinic to application-oriented basic research.

Dr. Ali Ata Tuz sitzt am Konfokalmikroskop und schaut frontal in die Kamera.. Auf dem Bildschirm nebem dem Mirkoskop sind in grün und violett Mikroskopaufnahmen von einer Probe im Mikroskop zu sehen.
8th July 2025

Heart Failure Rarely Occurs on Its Own: ISAS Researchers Develop New Treatment Pillars

The symptoms, subsequent problems and therapeutic challenges of patients with heart failure are increasingly challenging for general practitioners and cardiologists. Doctors are limited in their choice of treatment options, especially for patients with additional diseases. At ISAS, researchers are therefore focussing on broadening the therapeutic spectrum.

Prof. Dr. Kristina Lorenz.
25th June 2025

New Ionisation Method: From Open Questions to Closed Plasma

Mass spectrometry only works with electrically charged, i.e. ionised, particles. Researchers often use plasma for this purpose. In a series of publications, scientists from the Miniaturisation Research Group have shed new light on this ionisation method and presented a completely new type of plasma. This does not require a continuous gas flow and is therefore particularly resource-efficient.

Cayian Tian adjusts the gas supply to the plasma.
11th June 2025

“We essentially ask ourselves the same questions”

In the ISAS cooperation project “The Secret World of the Immune System”, ISAS researchers and artists from the storyLab kiU at Dortmund University of Applied Sciences and Arts brought microscope data to life in an immersive space. Lennart Oberscheidt, research associate and visual effects (VFX) supervisor at storyLab kiU, talks about the special features of the project and the similarities between art and research in an interview.

30th May 2025

What Can't Be Missing From Your Project, Laxmikanth Kollipara?

In many research projects, there is one thing that is essential for success. Perhaps a rare sample or a special device? For Dr Laxmikanth Kollipara, that one thing is a very special pillar from the PIPMet project.

Dr Laxmikanth Kollipara stands in the laboratory holding a silver-coloured column. In the background are HPLC systems.
14th May 2025

“Moving to ISAS changed my whole view on mass spectrometry”

Prof Dr Miloš Filipović is researching the connection between ageing processes and gasotransmitter signalling pathways, in particular hydrogen sulphide. The biochemist headed the ERC Sulfaging group at ISAS from October 2020 until February 2025, at which point he was appointed to the University of Glasgow in Scotland. In this interview, he looks back on the past four and a half years in Dortmund and talks about his experiences at ISAS.

Dr. habil. Milos Filipovic.
30th April 2025

Humboldt Fellow Prof Dr Xiaowei Xu started at ISAS in March

Prof Dr Xiaowei Xu from the Chinese Guangdong Cardiovascular Institute is researching the clinical application of artificial intelligence (AI) in the context of cardiovascular diseases. For 18 months in total, he will be researching various AI methods for analysing cell images as a Humboldt Fellow at ISAS.

Prof Dr Xiaowei Xu in front of the ISAS city building.
22nd April 2025

Valuable Connections: Dr Mohammad Ibrahim AlWahsh

Dr Mohammad Ibrahim AlWahsh worked as a research assistant at ISAS during his doctorate. He is now Vice Dean of the Faculty of Pharmacy and Assistant Professor of Toxicological Pathology at Al-Zaytoonah University in Jordan. In the Kompakt series ‘Valuable Connections,’ he reports on his time at ISAS and his ongoing network with the institute.

Mohammad Alwahsh.